Free CME from PeerView


Hematology CME

Credits: 1.0 CME / MOC / NCPD
Penn State College of Medicine
Mapping the Therapeutic Odyssey in Multiple Myeloma: Interprofessional Guidance on Evidence-Based Treatment Selection and Sequencing
Nina Shah, MD
May 09, 2022
Credits: 0.25 CME / CPE
Medical Learning Institute, Inc.
Making Sense of New Standards for CLL: Pharmacist Insights on Targeted Therapy and the Delivery of Team-Based Care
Amber C. King, PharmD, BCOP
May 06, 2022
Credits: 0.5 CME / MOC / NCPD
Medical Learning Institute, Inc.
Solving the Challenge of Tumor Lysis Syndrome: Expert Insight and Guidance on a Challenging Oncologic Emergency
Anthony R. Mato, MD, MSCE
April 04, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Primary Care Call to Action for VTE Management: Sharpening Skills in Recognition, Treatment, and Secondary Prevention
Geoffrey Barnes, MD, MSc
March 31, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
Complementary Actions All Around: Lowering Cardiometabolic Risks While Achieving Glycemic Targets With GLP-1 RAs
John B. Buse, MD, PhD
March 25, 2022
Purvi S. Parikh, MD, FACP, FACAAI/Cedric Jamie Rutland, MD
Credits: 1.0 CME
Medical Learning Institute, Inc.
Taking It From the Top: Targeting a New Approach to Controlling Severe Asthma
Purvi S. Parikh, MD / FACP, FACAAI/Cedric "Jamie" Rutland, MD
March 17, 2022
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Linking Immunotherapy to Better Outcomes in Resectable Melanoma: Guidance on Integrating Immune-Based Adjuvant and Neoadjuvant Options
Jennifer Wargo, MD, MMSc
March 10, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
Modern Management of ITP: Thinking Beyond the Conventional Therapies
Cindy Neunert, MD, MSCS
March 08, 2022
Credits: 0.5 CME / NCPD
Medical Learning Institute, Inc.
Breakthroughs in Spinal Muscular Atrophy: Managing the Life-Changing Impact of Gene Replacement Therapy
Julie Parsons, MD
March 01, 2022
Amit Bar-Or, MD, FRCPC/Daniel S. Reich, MD, PhD
Credits: 1.0 CME
Medical Learning Institute, Inc.
Rationale, Evidence, and Practical Potential for BTK Inhibitors in Patient-Centered MS Care: Where We Stand Now
Amit Bar-Or, MD, FRCPC / Daniel S. Reich, MD, PhD
February 26, 2022
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Putting the Pieces Together: Would You Recognize Acute Hepatic Porphyria If You Saw It?
Herbert L. Bonkovsky, MD
February 25, 2022
Credits: 1.0 CME / CC / NCPD / CPE
Medical Learning Institute, Inc.
Seeing Eye to Eye: Improving Outcomes Among Rural Spanish-Speaking Latinx Patients With Diabetic Retinopathy or Diabetic Macular Edema
J. Fernando Arevalo, MD, PhD, FACS
February 24, 2022
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Can the Addition of Immunotherapy to Multimodal Management of Stage I-III NSCLC Help Break the Stalled Cycle of Poor Outcomes?
Nasser Altorki, MD / Jonathan D. Spicer, MD / PhD, FRCSC
February 22, 2022
Pasi A. Janne, MD, PhD
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Addressing Key Targets in Advanced NSCLC: Evaluating the Latest Evidence and Clinical Opportunities for HER2-, HER3-, and TROP2-Targeted Therapies
Pasi A. Janne, MD, PhD
February 22, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Decisions and Dilemmas in Prostate Cancer Management: Building on Progress to Advance Personalized Care Through Candid Conversations and Expert Clinical Consults
Robert Dreicer, MD, MS, MACP, FASCO
February 19, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Achieving State-of-the-Art Care in Bladder Cancer in an Era of Innovative Therapeutic Solutions
Petros Grivas, MD, PhD
February 18, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Navigating Evolving Standards of Care in Renal Cell Carcinoma: Expert Insights on Selecting and Sequencing Targeted and Immunotherapy Options and a Look at Emerging Strategies
Sumanta Kumar Pal, MD, FASCO
February 18, 2022
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
The Rising Tide of Novel BTK Inhibitors: Case-Based Guidance on Overcoming Intolerance, Resistance, and Other Clinical Challenges in B-Cell Cancers
Anthony R. Mato, MD, MSCE
February 17, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Embracing the Era of Individualized Therapy in Advanced Biliary Cancers: Expert Strategies for Applying New and Emerging Targeted Treatment Options Through Precision Medicine
Milind Javle, MD
February 16, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Mapping the Optimal Treatment Route in HCC: Identifying Best Practices in an Expanding Therapeutic Landscape
Richard S. Finn, MD
February 15, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
Easing the Burden of Hypereosinophilic Syndrome: An Animated Exploration of the Role of Targeted Therapy to Improve Patient Outcomes
Paneez Khoury, MD, MHSc, FAAAAI
February 09, 2022
Credits: 0.5 CME / NCPD
American Psychiatric Nurses Association
Addressing Unmet Needs in the Management of Schizophrenia and Bipolar Disorder: New and Emerging Therapeutic Options to Enhance Treatment and Maximize Patient Outcomes
Alan "Tony" Amberg, APRN, PMHNP-BC
February 04, 2022
Erika Hamilton, MD
Credits: 1.0 CME
Medical Learning Institute, Inc.
Expanding Treatment Options in ER+/HER2- Breast Cancer: Expert Perspectives on the Rapidly Emerging Role of SERDs, SERMs, and SERCAs, and the Practical Considerations of Leveraging Established and Innovative Therapies
Erika Hamilton, MD
January 19, 2022
Michael Heinrich, MD
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Optimally Sequencing Modern TKIs in GIST: Expert Perspectives From an Interprofessional Sarcoma Team
Michael Heinrich, MD
January 13, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
Recent Advances and Novel Options in Depression: Reviewing the Evidence for GABA-Modulating Neuroactive Steroids for Major Depressive Disorder
Anita H. Clayton, MD
December 31, 2021
Credits: 0.5 CME
Medical Learning Institute, Inc.
Upstream and Downstream Targeting of the Complement Pathway to Manage PNH: Current and Emerging Inhibitors
Carlos M. de Castro, MD
December 31, 2021
John G. Gribben, MD, DSc, FRCP, FRCPath, FMedSci
Credits: 2.0 CME
Penn State College of Medicine
Achieving Innovation in CLL Care: Evidence-Informed Choices With Targeted Options and Next Steps in Disease Management
John G. Gribben, MD, DSc, FRCP, FRCPath, FMedSci
December 30, 2021
Credits: 0.5 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
A Closer Look at Telehealth for HIV: Best Practices for Patient Management in a Unique Era of Care
Christian B. Ramers, MD, MPH, AAHIVS
December 30, 2021
Professor Thomas Powles, MBBS, MRCP, MD
Credits: 1.0 CME
Medical Learning Institute, Inc.
Carrying Through in Advanced/Metastatic Urothelial Carcinoma: Expert Perspectives on Recent Practice‐Changing Data and the Practicalities of Individualizing and Continuing Care With Novel Immunotherapy Maintenance Strategies
Professor Thomas Powles, MBBS, MRCP, MD
December 29, 2021
Credits: 0.5 CME / MOC / CC / NCPD / CPE
Medical Learning Institute, Inc.
New Advances and Opportunities for Improvement in HR+/HER2- Early Breast Cancer: Practical Strategies for Optimal Clinical Integration of Adjuvant CDK4 and 6 Inhibitor Therapy
Sara M. Tolaney, MD, MPH
December 28, 2021

Pages

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView